In our daily conversations on the coronavirus on my Facebook page, I have shared a number of resources that can help us better understand this disease. Here, find a complete listing of those tools, sorted by video (and date).

• Day 3 (March 13, 2020)
  • Worldometer’s Coronavirus Report
• Day 4 (March 14, 2020)
  • Study: Convalescent plasma as a potential therapy for COVID-19
  • Study: The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application
  • Study: Vitamin D and the anti-viral state
  • Study: Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1
  • Clean & Disinfect: Interim Recommendations for US Households with Suspected/Confirmed Coronavirus Disease 2019 (CDC)
  • Novel Coronavirus (COVID-19)—Fighting Products
  • Experimental drug helps some Americans ride out Coronavirus, NIH doctor says
• Day 5 (March 15, 2020)
  • Study: Calcium and vitamin D in sarcoidosis: is supplementation safe?
  • Study: Zn²⁺ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell Culture
  • MedCram Coronavirus Epidemic Update 32
• Day 6 (Match 16, 2020)
  • A detailed guide to the coronavirus drugs and vaccines in development
  • Common Questions About the New Coronavirus Outbreak
  • CBN News Asks Noted Neurologist Your Questions About the Coronavirus Outbreak
  • Evaluating and Testing Persons for Coronavirus Disease 2019 (COVID-19)
  • Did an experimental drug help a U.S. coronavirus patient?
  • Study: Glutathione dysregulation and the etiology and progression of human diseases
  • Study: In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
• Day 7 (March 17, 2020)
  • Why Fighting the Coronavirus Depends on You
  • Urban Nature Experiences Reduce Stress in the Context of Daily Life Based on Salivary Biomarkers
  • How blood plasma from recovered patients could help treat the new coronavirus
  • WHO COVID-19 Resources Page
• Day 8 (March 18, 2020)
  • Synairgen to start trial of SNG001 in COVID-19 imminently
  • Japanese flu drug ‘clearly effective’ in treating coronavirus, says China
  • Estimating the generation interval for COVID-19 based on symptom onset data
  • Live tracker: How many coronavirus cases have been reported in each U.S. state?
• Day 9 (March 19, 2020)
  • Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020
  • Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists
  • Positive RT-PCR Test Results in Patients Recovered From COVID-19
• Day 10 (March 20, 2020)
  • Which Country Has Flattened the Curve for the Coronavirus?
  • Study: Influence of caloric restriction on aging immune system
  • Study: Caloric Restriction in Humans: An Update
  • Study: Fisetin is a senotherapeutic that extends health and lifespan
  • Study: Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient
• Day 12 (March 22, 2020)
  • Study: Synairgen to start trial of SNG001 in COVID-19 imminently
  • Study: Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists
  • Study: Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient
• Day 13 (March 23, 2020)
  • Study: Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients
• Day 14 (March 24, 2020)
  • Fair Allocation of Scarce Medical Resources in the Time of Covid-19
  • Study: US Military Scientists Hope To Have Coronavirus Therapeutic By Summer
• Day 17 (March 28, 2020)
  • The science of soap – here’s how it kills the coronavirus
  • Study: Curcumin Suppression of Cytokine Release and Cytokine Storm. A Potential Therapy for Patients with Ebola and Other Severe Viral Infections
• Day 18 (March 29, 2020)
  • Dr. Perlmutter’s Interview with Our Health Talks
  • Blog Post: “Actually, he may have a point.”
• Day 19 (March 30, 2020)
  • Study: Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection
  • Study: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
• Day 20 (March 31, 2020)
  • Masks Save Lives
• Day 21 (April 1, 2020)
  • Are Viruses Alive?
• Day 22 (April 2, 2020)
  • Study: Reinfection could not occur in SARS-CoV-2 infected rhesus macaques
  • COVID-19 Signs and Symptoms Tracker
  • SARS-COV-2 Diagnostic Pipeline
• Day 23 (April 3, 2020)
  • Ten Weeks to Crush the Curve
  • Study: Infants Born to Mothers With a New Coronavirus (COVID-19)
  • Study: Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development
  • Study: Fisetin is a senotherapeutic that extends health and lifespan
  • Study: COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection?
  • Study: Increased Risk of Noninfluenza Respiratory Virus Infections Associated With Receipt of Inactivated Influenza Vaccine
• Day 24 (April 4, 2020)
  • Study: A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (COVID-19)
  • Study: Influence of caloric restriction on aging immune system
  • Study: Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19)
  • Study: Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19)
• Day 25 (April 5, 2020)
  • FDA Approves Phase III Clinical Trial of Tocilizumab for COVID-19 Pneumonia
  • Study: Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription
  • Study: Curcumin: An Effective Inhibitor of Interleukin-6.
  • Study: The Effect of Diaphragmatic Breathing on Attention, Negative Affect and Stress in Healthy Adults
  • Study: Role of Intermittent Fasting on Improving Health and Reducing Diseases
  • Study: Emerging Anti-Aging Strategies – Scientific Basis and Efficacy
• Day 26 (April 6, 2020)
  • Study: The coronavirus pandemic and aerosols: Does COVID-19 transmit via expiratory particles?
  • Study: Fasting as a Therapy in Neurological Disease
  • Coronavirus in the United States: Mapping the COVID-19 outbreak in the states and counties
• Day 28 (April 8, 2020)
  • Study: The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro
  • Study: Hypertension and COVID-19
• Day 29 (April 13, 2020)
  • Study: COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection?
  • Study: Duration of SARS-CoV-2 viral shedding during COVID-19 infection
  • Study: Prolonged viral shedding in feces of pediatric patients with coronavirus disease 2019
• Day 30 (April 14, 2020)
  • Study: To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic
  • Study: Regulators split on antimalarials for COVID-19
• Day 31 (April 16, 2020)
  • Study: Arbidol Monotherapy is Superior to Lopinavir/ritonavir in Treating COVID-19
  • Study: The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2
  • Study: Gastrointestinal symptoms as the first, atypical indication of SARS-CoV-2 infection
• Day 32 (April 18, 2020)
  • Study: Universal Screening for SARS-CoV-2 in Women Admitted for Delivery
  • Study: Neurologic Features in Severe SARS-CoV-2 Infection
  • Study: Exhaled breath condensate as a potential specimen for diagnosing COVID-19
  • Study: Treatment with convalescent plasma for COVID‐19 patients in Wuhan, China
• Day 34 (April 24, 2020)
  • Study: Tracing New Clinical Manifestations in Patients with COVID-19 in Chile and its Potential Relationship with the SARS-CoV-2 Divergence
• Day 35 (April 28, 2020)
  • Study: Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
  • Study: Obesity hypoventilation syndrome and severe COVID-19
  • Study: COVID-19 and Underinvestment in the Health of the US Population
• Day 39 (May 9, 2020)
  • Study: What policy makers need to know about COVID-19 protective immunity
  • Study: Emergence of genomic diversity and recurrent mutations in SARS-CoV-2
  • Germ Defence
• Day 40 (May 12, 2020)
  • Study: Two-Year Prospective Study of the Humoral Immune Response of Patients with Severe Acute Respiratory Syndrome
  • Study: Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
  • Study: Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths
  • Study: The western diet and lifestyle and diseases of civilization
• Day 41 (May 21, 2020)
  • Study: Intravenous vitamin C for reduction of cytokines storm in acute respiratory distress syndrome
  • Study: ABO blood group predisposes to COVID-19 severity and cardiovascular diseases